Evaluating the Safety and Immunogenicity of HIV-1 BG505 SOSIP.664 gp140 With TLR Agonist and/or Alum Adjuvants in Healthy, HIV-uninfected Adults
Clinical trial NCT04177355 · COMPLETED
Trial details
- NCT number
- NCT04177355
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2024-11-04
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.